Find News

Filter articles

Showing 6441 to 6450 of 7516 results

Indian Patent Office handed extra responsibilities


The Indian Patent Office (IPO) has been officially recognised as an International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA).

Interpol looks to private sector in counterfeiting fight


Greater cooperation between the public and private sectors is needed to combat counterfeiting, Interpol’s secretary general told a conference in Dublin.

Samsung told to reveal emails in Apple battle


Samsung has failed to overturn a ruling requiring it to reveal documentation relating to an alleged leak of secret files belonging to rival Apple.

Italian Supreme Court rules in Budweiser feud


The Italian Supreme Court has recommended banning Anheuser-Busch InBev (ABI) from using the ‘Budweiser’ trademark after ruling in a dispute with Czech rival Budějovický Budvar.

UK TV streaming service ordered to remove channels


A UK TV streaming service has been ordered to stop broadcasting certain channels online and through mobile phones after it was found guilty of copyright infringement.

Bloomberg secures injunction in India


Financial news company Bloomberg has been granted a preliminary injunction against a host of “paper” companies that infringed its trademark.

Luxury brands celebrate counterfeiting victory


A group of luxury brand owners has secured a permanent injunction against three websites whose operators knowingly facilitated counterfeiting.

Newly named UK court issues first judgement


The Intellectual Property Enterprise Court, formerly the Patents County Court, has issued the first judgement under a new name following its re-branding at the start of the month.

Cook to leave Bird & Bird for WilmerHale

UK, US15-10-2013Movers & Shakers

After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York.

Myriad hit with gene testing suit


US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics.

Showing 6441 to 6450 of 7516 results